Solène Hébert
Impact in
- Epidemiology top 5%
- Acute Ischemic Stroke Management
- Neurology top 10%
- Long-Term Effects of COVID-19
- Intracranial Aneurysms: Treatment and Complications
Papers in
- Epidemiology 24
- Acute Ischemic Stroke Management 24
-
- Cerebrovascular and Carotid Artery Diseases 3
- Co-authors
- Jean‐Philippe Désilles (11 shared papers)François Delvoye (11 shared papers)Raphaël Blanc (11 shared papers)Michel Piotin (11 shared papers)Mikaël Mazighi (11 shared papers)Simon Escalard (11 shared papers)Hocine Redjem (11 shared papers)Benjamin Maïer (11 shared papers)
In The Last Decade
Solène Hébert
26 papers receiving 771 citations
Solène Hébert's Hit Papers
Peers
Comparison fields: 5 of 37
- Epidemiology 591
- Neurology 144
- Infectious Diseases 106
- Oncology 107
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Solène Hébert
This map shows the geographic impact of Solène Hébert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solène Hébert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solène Hébert more than expected).
Fields of papers citing papers by Solène Hébert
This network shows the impact of papers produced by Solène Hébert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solène Hébert. The network helps show where Solène Hébert may publish in the future.
Co-authors
The 25 scholars most cited alongside Solène Hébert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial Hit paper breakdown → | 2021 | 161 |
| 2 | 2020 | 146 | |
| 3 | 2020 | 127 | |
| 4 | 2020 | 50 | |
| 5 | 2020 | 34 | |
| 6 | 2020 | 26 | |
| 7 | 2020 | 24 | |
| 8 | 2020 | 23 | |
| 9 | 2020 | 20 | |
| 10 | 2022 | 20 | |
| 11 | 2022 | 19 | |
| 12 | 2020 | 16 | |
| 13 | 2021 | 16 | |
| 14 | 2019 | 15 | |
| 15 | 2022 | 15 | |
| 16 | 2022 | 14 | |
| 17 | 2021 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2020 | 8 |
About Solène Hébert
Solène Hébert is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Neurology, Infectious Diseases and Immunology, having authored 27 papers that have together received 801 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (24 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), COVID-19 and healthcare impacts (1 paper), COVID-19 Clinical Research Studies (1 paper) and Intracranial Aneurysms: Treatment and Complications (1 paper). The work is most often cited by research in Epidemiology (591 citations), Neurology (144 citations), Infectious Diseases (106 citations), Oncology (107 citations) and Pulmonary and Respiratory Medicine (58 citations). Solène Hébert has collaborated with scholars based in France, Canada and Belgium. Frequent co-authors include Jean‐Philippe Désilles, François Delvoye, Raphaël Blanc, Michel Piotin, Mikaël Mazighi, Simon Escalard, Hocine Redjem, Benjamin Maïer, Stanislas Smajda and Gabriele Cicciò. Their work appears in journals such as Stroke, Journal of NeuroInterventional Surgery, Journal of Stroke and Cerebrovascular Diseases, Frontiers in Neurology and Clinical Neuroradiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.